My Health

My Health, founded by Raf Dybajlo in 2017, is a biotechnology company specializing in microbiome solutions. In 2021, the company published a clinical study in The Lancet Gastroenterology & Hepatology, introducing the efficacy of My Health's patented strains MY01 and MY02 in treating functional dyspepsia (unexplained gastrointestinal discomfort).